Treatment for Delayed Sleep-Wake Phase Disorder in Psychiatric Patients
Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Delayed Sleep-Wake Phase Disorder (DSWPD)
This study is testing a group treatment that uses bright light therapy to help people with sleep problems and mental health issues feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Haukeland University Hospital Academic / other |
| Locations | 2 sites (Bergen, Tertnes and 1 other locations) |
| Trial ID | NCT05177055 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of group-based treatment for Delayed Sleep-Wake Phase Disorder (DSWPD) in patients with comorbid psychiatric illnesses. Participants will receive bright light therapy at gradually advanced timings, with some also using blue-blocking glasses to enhance treatment efficacy. The study aims to assess both sleep and psychiatric symptoms through a randomized controlled trial format, leveraging an established sleep-school model at Bjørgvin District Psychiatric Hospital. Individual consultations will ensure participants meet eligibility criteria before joining the group sessions.
Who should consider this trial
Good fit: Ideal candidates are patients referred to the sleep-school who meet DSM-V criteria for DSWPD and have moderate to severe psychiatric illness.
Not a fit: Patients who work night shifts or do not meet the diagnostic criteria for DSWPD may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve sleep quality and psychiatric symptoms in patients with DSWPD.
How similar studies have performed: Previous studies have shown promising results for similar interventions in treating sleep disorders in psychiatric populations, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients referred to the sleep-school at Bjørgvin DPS psychiatric hospital * Patients fulfilling the Diagnostic Manual for Mental Disorders (DSM-V) criteria for DSWPD comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the International Statistical Classification of Diseases and Related Health Problems (ICD-11) diagnostic system that are used in Norway in addition to DSWPD and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school) Exclusion Criteria: * Night work * Patients that do not fulfil the DSM-V criteria for DSWPD comorbid to moderate to severe psychiatric illness (confirmed F-diagnosis based on the ICD-10 diagnostic system that are used in Norway in addition to insomnia and/or scores of ≥19 on BDI and/or scores of ≥16 on BAI at the time of referral to the sleep school)
Where this trial is running
Bergen, Tertnes and 1 other locations
- Haukeland University Hospital — Bergen, Tertnes, Norway (Recruiting)
- Haukeland University Hospital — Bergen, Norway (Recruiting)
Study contacts
- Principal investigator: Ane Wilhelmsen-Langeland, PhD — Haukeland University Hospital
- Study coordinator: Ane Wilhelmsen-Langeland, PhD
- Email: ane.wilhelmsen-langeland@helse-bergen.no
- Phone: +47 55957000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.